Annual report pursuant to Section 13 and 15(d)

Document and Entity Information

Document and Entity Information - USD ($)
12 Months Ended
Jul. 31, 2019
Nov. 18, 2019
Jan. 31, 2019
Document And Entity Information      
Entity Registrant Name ONCOSEC MEDICAL Inc    
Entity Central Index Key 0001444307    
Document Type 10-K/A    
Document Period End Date Jul. 31, 2019    
Amendment Flag true    
Amendment Description This Amendment No. 1 to the Company's Annual Report on Form 10-K for the fiscal year ended July 31, 2019 ("Amendment No. 1"), as filed with the Securities and Exchange Commission (the "SEC") on October 28, 2019 (the "Original Filing"), is being filed to provide the information required pursuant to Items 10, 11, 12, 13 and 14 of Part III of Form 10-K. This information was previously omitted from the Original Filing in reliance on General Instruction G(3) to Form 10-K, which provides that registrants may incorporate by reference certain information from a definitive proxy statement which involves the election of directors if such definitive proxy statement is filed with the SEC within 120 days after fiscal year end.Pursuant to Rule 12b-15 under the Securities and Exchange Act of 1934, as amended, this Amendment No. 1 amends the Original Filing and contains new certifications pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act of 2002.Except as stated herein, this Amendment No. 1 does not reflect events occurring after the filing of the Original Filing and does not amend or otherwise update any other information in the Original Filing. Accordingly, this Amendment No. 1 should be read in conjunction with the Company's other filings made with the SEC subsequent to the filing of the Original Filing, including any amendments to those filings.    
Current Fiscal Year End Date --07-31    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filer No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business Flag true    
Entity Emerging Growth Company false    
Entity Ex Transition Period false    
Entity Shell Company false    
Entity Public Float     $ 47,184,790
Entity Common Stock, Shares Outstanding   10,695,428  
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2019